PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

68 hedge funds and large institutions have $49.4M invested in PDS Biotechnology in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 12 closing their positions.

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
27
Reduced
12
Closed
12
Calls
$2.5M
Puts
$484K
Net Calls
+$2.01M
Net Calls Change
-$7.53M

Top Buyers

1
EWA
1
EP Wealth Advisors
California
$2.91M
2
Qube Research & Technologies (QRT)
2
Qube Research & Technologies (QRT)
United Kingdom
$1.24M
3
Millennium Management
3
Millennium Management
New York
$3.67M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.99M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$2.25M

Top Sellers

1
EI
1
EAM Investors
California
$0
2
EGI
2
EAM Global Investors
California
$0
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$1M
4
Morgan Stanley
4
Morgan Stanley
New York
$639K
5
KAM
5
Knightsbridge Asset Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LIP
76
Lighthouse Investment Partners
Florida
– -$148K -11,190 Closed
Rockefeller Capital Management
77
Rockefeller Capital Management
New York
– -$45K -3,413 Closed
FWA
78
Freedom Wealth Alliance
Wisconsin
– -$29.2K -2,211 Closed
FIA
79
FNY Investment Advisers
New York
– -$13K -993 Closed
RCM
80
Raleigh Capital Management
North Carolina
– -$607 -46 Closed
1 2 3
4